The CAST-HF Registry is a clinical database collecting real-world evidence on the application of shockwave therapy in patients with heart failure. It serves as a platform to monitor safety, efficacy, and long-term outcomes of this innovative, non-invasive treatment. The trial is going to be a prospective, multicenter, investigator-initiated, observational registry. The participating medical centers are located in Europe.
TBA
TBA
2026
up to 3 years
Prospective Evaluation of short- and long-term safety and efficacy of direct epicardial cardiac shockwave therapy
To Capture potential rare adverse events and improve understanding of subgroups
To Collect patient and physician feedback on therapy acceptance
To Gather long-term data on functional capacity, symptoms, and quality of life
Musterstraße 3
12345 Musterstadt
Musterstraße 3
12345 Musterstadt
Musterstraße 3
12345 Musterstadt
Musterstraße 3
12345 Musterstadt
Musterstraße 3
12345 Musterstadt
Musterstraße 3
12345 Musterstadt
